Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Predicting 5- and 10-year survival in older women with early-stage breast cancer: self-rated health and walking ability.

Eng JA, Clough-Gorr K, Cabral HJ, Silliman RA.

J Am Geriatr Soc. 2015 Apr;63(4):757-62. doi: 10.1111/jgs.13340.

PMID:
25900489
2.

The diffusion of docetaxel in patients with metastatic prostate cancer.

Unger JM, Hershman DL, Martin D, Etzioni RB, Barlow WE, LeBlanc M, Ramsey SR.

J Natl Cancer Inst. 2014 Dec 24;107(2). pii: dju412. doi: 10.1093/jnci/dju412. Print 2015 Feb.

PMID:
25540245
3.

Patient age is related to decision-making, treatment selection, and perceived quality of life in breast cancer survivors.

Sio TT, Chang K, Jayakrishnan R, Wu D, Politi M, Malacarne D, Saletnik J, Chung M.

World J Surg Oncol. 2014 Jul 22;12:230. doi: 10.1186/1477-7819-12-230.

4.

Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.

Garg G, Yee C, Schwartz K, Mutch DG, Morris RT, Powell MA.

Gynecol Oncol. 2014 May;133(2):242-9. doi: 10.1016/j.ygyno.2014.02.021. Epub 2014 Feb 19.

5.

Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care system.

Zhou J, Enewold L, Zahm SH, Jatoi I, Shriver C, Anderson WF, Jeffery DD, Andaya A, Potter JF, McGlynn KA, Zhu K.

Am J Surg. 2013 Sep;206(3):393-9. doi: 10.1016/j.amjsurg.2013.01.034. Epub 2013 Jul 16.

6.

Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.

Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1115-25. doi: 10.1158/1055-9965.EPI-11-1228. Epub 2012 May 9.

7.

Cancer survivors: a booming population.

Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):1996-2005. doi: 10.1158/1055-9965.EPI-11-0729.

8.

Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.

Hoffman KE, Neville BA, Mamon HJ, Kachnic LA, Katz MS, Earle CC, Punglia RS.

Cancer. 2012 Jan 1;118(1):248-57. doi: 10.1002/cncr.26248. Epub 2011 Jun 20.

9.

Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival.

Strauss J, Hershman DL, Buono D, McBride R, Clark-Garvey S, Woodhouse SA, Abrams JA, Neugut AI.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1404-12. doi: 10.1016/j.ijrobp.2009.03.050. Epub 2009 Jun 18.

10.

Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer.

Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R.

J Cancer Surviv. 2009 Jun;3(2):89-98. doi: 10.1007/s11764-009-0084-3. Epub 2009 May 13.

11.

Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004.

Shen Y, Dong W, Feig BW, Ravdin P, Theriault RL, Giordano SH.

Cancer. 2009 May 15;115(10):2041-51. doi: 10.1002/cncr.24271.

12.

Cancer survivorship and aging : moving the science forward.

Bellizzi KM, Mustian KM, Palesh OG, Diefenbach M.

Cancer. 2008 Dec 15;113(12 Suppl):3530-9. doi: 10.1002/cncr.23942. Review.

13.

Aging in the context of cancer prevention and control : perspectives from behavioral medicine.

Bellizzi KM, Mustian KM, Bowen DJ, Resnick B, Miller SM.

Cancer. 2008 Dec 15;113(12 Suppl):3479-83. doi: 10.1002/cncr.23937. No abstract available.

14.

Use of intravenous bisphosphonates in older women with breast cancer.

Giordano SH, Fang S, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS.

Oncologist. 2008 May;13(5):494-502. doi: 10.1634/theoncologist.2007-0200.

15.

Predictors of multivisceral resection in patients with locally advanced colorectal cancer.

Govindarajan A, Fraser N, Cranford V, Wirtzfeld D, Gallinger S, Law CH, Smith AJ, Gagliardi AR.

Ann Surg Oncol. 2008 Jul;15(7):1923-30. doi: 10.1245/s10434-008-9930-1. Epub 2008 May 13.

16.

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005.

Cronin-Fenton DP, Nørgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sørensen HT.

Br J Cancer. 2007 May 7;96(9):1462-8. Epub 2007 Apr 3.

17.

Methodology, design, and analytic techniques to address measurement of comorbid disease.

Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA.

J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3):281-5. Review.

18.

Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography.

Polsky D, Armstrong KA, Randall TC, Ross RN, Even-Shoshan O, Rosenbaum PR, Silber JH.

Health Serv Res. 2006 Dec;41(6):2201-18.

19.

Impact of a scientific presentation on community treatment patterns for primary breast cancer.

Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Freeman J, Goodwin JS.

J Natl Cancer Inst. 2006 Mar 15;98(6):382-8.

20.

How good is the quality of health care in the United States? 1998.

Schuster MA, McGlynn EA, Brook RH.

Milbank Q. 2005;83(4):843-95. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk